Validation of Fibroblast-Derived PI16 As A Novel Target for Pain Treatment

Grant

Date/time Interval

  • September 30, 2020 - August 31, 2024
  • Total Award Amount

  • 121956.00
  • Direct Costs

  • 82125.00
  • Sponsor Award Id

  • 3001633945
  • Contributor

  • Eroboghene Ubogu   Principal Investigator